BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7824722)

  • 1. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
    Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
    Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.
    Martin WH; Delbeke D; Patton JA; Sandler MP
    Radiology; 1996 Jan; 198(1):225-31. PubMed ID: 8539384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress.
    Drane WE; Abbott FD; Nicole MW; Mastin ST; Kuperus JH
    Radiology; 1994 May; 191(2):461-5. PubMed ID: 8153322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-SPECT: correlation with FDG-PET.
    Martin WH; Delbeke D; Patton JA; Hendrix B; Weinfeld Z; Ohana I; Kessler RM; Sandler MP
    J Nucl Med; 1995 Jun; 36(6):988-95. PubMed ID: 7769457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
    Mukherji SK; Drane WE; Mancuso AA; Parsons JT; Mendenhall WM; Stringer S
    Radiology; 1996 Jun; 199(3):761-6. PubMed ID: 8638002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG).
    Drane WE; Nicole MW; Mastin ST; Kuperus JH
    Radiology; 1995 Nov; 197(2):341-2; discussion 343. PubMed ID: 7480674
    [No Abstract]   [Full Text] [Related]  

  • 7. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
    Shulkin BL; Mitchell DS; Ungar DR; Prakash D; Dole MG; Castle VP; Hernandez RJ; Koeppe RA; Hutchinson RJ
    Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of thallium-201 and F-18 FDG SPECT uptake in squamous cell carcinoma of the head and neck.
    Mukherji SK; Drane WE; Tart RP; Landau S; Mancuso AA
    AJNR Am J Neuroradiol; 1994 Nov; 15(10):1837-42. PubMed ID: 7863932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.
    Burt RW; Perkins OW; Oppenheim BE; Schauwecker DS; Stein L; Wellman HN; Witt RM
    J Nucl Med; 1995 Feb; 36(2):176-9. PubMed ID: 7830109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer.
    Inokuma T; Tamaki N; Torizuka T; Fujita T; Magata Y; Yonekura Y; Ohshio G; Imamura M; Konishi J
    J Nucl Med; 1995 Feb; 36(2):229-35. PubMed ID: 7830119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
    Gritters LS; Francis IR; Zasadny KR; Wahl RL
    J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose.
    Lapela M; Grénman R; Kurki T; Joensuu H; Leskinen S; Lindholm P; Haaparanta M; Ruotsalainen U; Minn H
    Radiology; 1995 Oct; 197(1):205-11. PubMed ID: 7568825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine 18F-2-deoxy-2-fluoro-D-glucose (18F-FDG) myocardial tomography using a normal large field of view gamma-camera.
    Höflin F; Ledermann H; Noelpp U; Weinreich R; Rösler H
    Angiology; 1989 Dec; 40(12):1058-64. PubMed ID: 2596740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT imaging of fluorine-18.
    Leichner PK; Morgan HT; Holdeman KP; Harrison KA; Valentino F; Lexa R; Kelly RF; Hawkins WG; Dalrymple GV
    J Nucl Med; 1995 Aug; 36(8):1472-5. PubMed ID: 7629597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
    Stollfuss JC; Glatting G; Friess H; Kocher F; Berger HG; Reske SN
    Radiology; 1995 May; 195(2):339-44. PubMed ID: 7724750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Performance of a multispect 2 gamma camera for imaging 511-keV gamma rays].
    Schaefer A; Oberhausen E
    Nuklearmedizin; 1995 Feb; 34(1):40-6. PubMed ID: 7724363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose.
    Hoh CK; Hawkins RA; Glaspy JA; Dahlbom M; Tse NY; Hoffman EJ; Schiepers C; Choi Y; Rege S; Nitzsche E
    J Comput Assist Tomogr; 1993; 17(4):582-9. PubMed ID: 8331230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer detection with whole-body FDG PET images without attenuation correction].
    Yasuda S; Ide M; Takagi S; Shohtsu A; Mitomi T; Kobayashi S; Suzuki Y
    Kaku Igaku; 1996 Apr; 33(4):367-73. PubMed ID: 8683875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT.
    Holle LH; Trampert L; Lung-Kurt S; Villena-Heinsen CE; Püschel W; Schmidt S; Oberhausen E
    J Nucl Med; 1996 Apr; 37(4):615-22. PubMed ID: 8691251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.